1. Home
  2. CWBC vs OMER Comparison

CWBC vs OMER Comparison

Compare CWBC & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CWBC

Community West Bancshares

HOLD

Current Price

$26.89

Market Cap

644.3M

Sector

Finance

ML Signal

HOLD

Logo Omeros Corporation

OMER

Omeros Corporation

HOLD

Current Price

$9.27

Market Cap

772.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWBC
OMER
Founded
1989
1994
Country
United States
United States
Employees
341
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
644.3M
772.8M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
CWBC
OMER
Price
$26.89
$9.27
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$28.63
$32.50
AVG Volume (30 Days)
578.3K
2.3M
Earning Date
04-23-2026
05-14-2026
Dividend Yield
2.03%
N/A
EPS Growth
N/A
98.15
EPS
N/A
0.62
Revenue
N/A
$29,868,000.00
Revenue This Year
$39.58
N/A
Revenue Next Year
$17.64
$233.22
P/E Ratio
$12.13
$14.97
Revenue Growth
N/A
N/A
52 Week Low
$18.51
$3.34
52 Week High
$27.73
$17.65

Technical Indicators

Market Signals
Indicator
CWBC
OMER
Relative Strength Index (RSI) 68.26 40.66
Support Level $23.38 $9.12
Resistance Level N/A $11.88
Average True Range (ATR) 0.65 0.92
MACD 0.13 0.04
Stochastic Oscillator 73.75 62.40

Price Performance

Historical Comparison
CWBC
OMER

About CWBC Community West Bancshares

Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments. The company has one reportable segment: Banking operations. Loans and leases, investment securities, interest-bearing deposits and non-interest income provide the revenues of the banking operation.

About OMER Omeros Corporation

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Share on Social Networks: